Strides Pharma Science incurs Rs 162.55 cr. loss in Q2FY22
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The new facility will provide an important boost to vaccine capacity in Africa
It is the world’s first DNA-based Covid vaccine
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
Acute therapies continue to report strong growth compared to chronic ones.
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
Subscribe To Our Newsletter & Stay Updated